Indium 111-labeled leukocyte scanning for detection of prosthetic vascular graft infection.
Recent animal and human studies have suggested that positive indium 111-labeled leukocyte scans may help establish the diagnosis of vascular graft infection; however, there is little information available about the predictive value of both positive and negative leukocyte scans in larger groups of patients. In this study 31 indium 111 leukocyte scans were performed prior to definitive treatment in 21 patients with suspected vascular graft infections. Patients with more than one leukocyte scan performed had either anatomically distinct sites of infection or rescanning of a potentially infected site after definitive treatment. Scans were performed according to the method of Baker et al., attaching 500 muCi of indium 111 to leukocytes with imaging 24 hours later. All patients with positive scans underwent surgical exploration of the area of leukocyte accumulation, with documentation of purulence and culture of the graft. Patients with negative scans were treated as if scan results were indeterminate and underwent surgical exploration for usual clinical indications; if no exploration was performed, the patient was followed up closely for at least 1 year. Twelve of 12 positive scans showed purulence or culture evidence of infection with three different organisms; in 15 instances of negative scans, two operations were performed with one infection noted, whereas no patient without surgery has had a graft infection at 10 months follow-up. In addition to localizing graft infections, two scans demonstrated a nonvascular site of infection. Positive scans also helped determine the extent of infection along the graft, allowing better planning of the surgical procedure. These results indicate that indium 111-labeled leukocyte scans help document and localize prosthetic vascular graft infections.
Lawrence
P F
PF
Dries
D J
DJ
Alazraki
N
N
Albo
D
D
D000368:Aged; D001424:Bacterial Infections / Q000000981:diagnostic imaging* / Q000601:surgery; D001807:Blood Vessel Prosthesis / Q000009:adverse effects*; D005260:Female; D006801:Humans; D006912:Hydroxyquinolines; D007204:Indium; D007962:Leukocytes; D008297:Male; D008875:Middle Aged; D009942:Organometallic Compounds; D015125:Oxyquinoline / Q000031:analogs & derivatives; D011093:Polyethylene Terephthalates; D011138:Polytetrafluoroethylene; D011868:Radioisotopes; D011877:Radionuclide Imaging; D012086:Reoperation; D013530:Surgical Wound Infection / Q000000981:diagnostic imaging* / Q000601:surgery
D006912:Hydroxyquinolines; D009942:Organometallic Compounds; D011093:Polyethylene Terephthalates; D011868:Radioisotopes; D007204:Indium; C032950:indium oxine; D015125:Oxyquinoline; D011138:Polytetrafluoroethylene